News

Class Action Filed Against ZoomInfo Technologies, Inc. - ZI

Class Action Filed Against ZoomInfo Technologies, Inc. - ZI

Overview of the Class Action Against ZoomInfo Technologies

Pomerantz LLP is taking action as a class action lawsuit has been initiated against ZoomInfo Technologies, Inc. (NASDAQ: ZI). This case is significant for shareholders, especially those who believe they may have been misled by the company's prior announcements and financial reporting.

Details of the Lawsuit

The lawsuit revolves around allegations of securities fraud and potential misconduct by certain officers and directors of ZoomInfo. Investors who acquired securities during the Class Period have until a specified deadline to seek to join as Lead Plaintiff for the class.

Timeline for Participation

Shareholders are encouraged to reach out if they purchased ZoomInfo's securities in order to understand their rights and potential entitlements concerning the class action. It’s important to act before the court’s deadline to ensure participation in this legal process.

Financial Context Behind Allegations

In a recent financial disclosure, ZoomInfo announced second-quarter earnings that notably fell short of analyst expectations. The reported adjusted earnings per share were $0.17 against the consensus of $0.24. Additionally, ZoomInfo experienced a year-over-year revenue decline, reporting $291.5 million, which was below the anticipated $307.68 million.

Implications of Financial Shortcomings

These disappointing financial results have raised questions about the company’s growth strategy and operational transparency. Notably, the firm incurred a substantial charge of $33 million due to customer non-payments, highlighting potential vulnerabilities in its business model. This charge relates back to revenues recorded in prior periods, which has prompted concerns about the legitimacy of the reported figures.

Impact on ZoomInfo’s Stock Performance

The negative news led to a significant decrease in ZoomInfo's stock price, with shares falling over 18% in a single day. The decline to $8.01 per share underscores the volatility surrounding the company and suggests investor sentiment is heavily influenced by these legal and financial developments.

About Pomerantz LLP

Pomerantz LLP stands as a leading law firm specializing in securities class actions and corporate litigation. Established by a pioneer in the field, the firm has a long history of advocating for investors' rights. With offices in major cities, they continue to champion for justice on behalf of claimants who have suffered from securities fraud and corporate misconduct.

Why Engage with Pomerantz LLP?

Individuals seeking redress for potential financial losses due to the alleged mismanagement at ZoomInfo are advised to consult with Pomerantz. The firm’s commitment to recovering damages on behalf of affected shareholders is evident in their extensive track record.

Contact Information

For those interested in this ongoing legal matter, it's vital to connect with Pomerantz LLP. Prospective plaintiffs can reach out directly to inquire about their eligibility and options regarding this class action.

Frequently Asked Questions

What is the main allegation against ZoomInfo Technologies?

The lawsuit alleges securities fraud and claims that certain officers and directors may have misled investors about the company’s financial health.

Who can join the class action?

Shareholders who purchased or acquired ZoomInfo securities during the specified Class Period are encouraged to participate.

What are the financial details reported by ZoomInfo?

ZoomInfo reported adjusted earnings of $0.17 per share and revenues of $291.5 million, both below expectations, leading to concerns over their financial management.

How did the stock market react to the news?

Following the disclosure of financial results and the associated charges, ZoomInfo's stock price dropped by 18.27% in one day, indicating significant investor reaction.

What should investors do if affected?

Affected investors should reach out to Pomerantz LLP to discuss their options for joining the class action and potentially recovering damages.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Testing Grounds: Navigating PRN Test Insights

Updated Category News Views 1

Deciphering the PRN Tester Repetition Today we're staring at what feels like déjà vu—a simple PR test peppered with the classic sentence about a fox and a dog. It's like someone left the 'repeat' function stuck on during a slow day at the office. But hey, let’s dig in. Is there something more behind this repetitive text, or are we grumbling at a wall? Unpacking the...

Continue Reading
TECNO's Modular Phone and Mini-PC Win Big at IFA 2026

Updated Category News Views 1

The Tale of Two Game-Changers TECNO has just scooped up two big-time awards, and I'm here to break it down like no glossy magazine ever could. Picture this: a brand that knows how to keep its foot on the innovation pedal and doesn't shy away from shaking up the tech world. TECNO's got the goods, claiming two prestigious IFA Global Product Technology Innovation Awards this...

Continue Reading
HKC and KOORUI Shine Bright at 2026 Berlin Awards

Updated Category News Views 3

Display Titans Take Center Stage in Berlin Look, in this game of display tech, you either adapt or get left in the dust. At the 2026 Global Product Technology Innovation Awards in Berlin, we saw two names rise to the top—HKC and its acclaimed brand KOORUI. They didn't just show up; they grabbed the spotlight with two major honors. Award Spotlights: A Breakdown HKC took...

Continue Reading
Signant and Lothar Forge Future in Clinical Trials

Updated Category News Views 2

Breathing New Life into Clinical Trials Alright, folks, listen up. We've got a fresh collaboration cooking that could shake things up in the clinical trial sector. Signant Health, a heavyweight in clinical trial solutions, has teamed up with Lothar Medical, and they’ve hitched their wagons to launch something rather intriguing: the ALDS PRO pulmonary function tech. Let...

Continue Reading
LiberNovo Spotlights Ergonomic Seating at Berlin's IFA 2026

Updated Category News Views 1

LiberNovo Sets the Stage at IFA 2026 If you're poking around Berlin this September, the Messe Berlin is the place to be, especially for those keeping tabs on the consumer tech world. LiberNovo, the ergonomic seating company you might not have had on your radar, is out here making noise. They're throwing down the gauntlet with the Maxis Series, promising a better deal for...

Continue Reading
Affleck Joins Aflac in Unlikely Yet Fitting Alliance

Updated Category News Views 2

A Partnership Born from a Punning Connection Look, in this world of insurance and Hollywood glitz, it's not every day you see Ben Affleck sharing the screen with a talking duck. But here we are. Aflac—the giant in supplemental health insurance—and Ben Affleck have cozied up for a series of ads under Affleck’s direction, breathing life into what started as nothing...

Continue Reading
Hims & Hers Faces Legal Storm Over Alleged Privacy Breaches

Updated Category News Views 4

Legal Storms Brew Over Alleged Privacy Breaches Well, here we go again, folks. Just when you think the waters are calming, Hims & Hers Health, Inc. (NYSE: HIMS) finds itself in the thick of a nasty securities fraud class action lawsuit. Allegedly they've been less than honest with their customers' health info—something about sneaking around with people's sensitive data...

Continue Reading
Evolve & ELITEWHEELS: Shifting Gears in European Cycling

Updated Category News Views 3

Revving Up for the European Cycling Scene There's something about the open road and the whirr of wheels that gets blood pumping—maybe it's the competition, maybe it's the gear. Either way, this year's Italian Bike Festival is turning the Misano World Circuit into a battleground for cycling's elite, with evolve and ELITEWHEELS charging at the forefront. They're not just...

Continue Reading
Virterion Surges Ahead in VPS Racing With Reliable Hosting

Updated Category News Views 3

Why Virterion Stands Out in 2026 VPS Landscape For anyone knee-deep in the hosting game, you know the market's got more players than a late-night poker round. Virterion, though—that's a name carving out a noticeable niche, and for solid reasons. In 2026, the backdrop's not just speed, it’s about matching technology and support with what ambitious developers need. VPS...

Continue Reading
Roborock Fuels Market Surge with 27.6% Revenue Boost

Updated Category News Views 1

Roborock's Rocket-Like Ascent in Global Markets Call me impressed, but Roborock is really hitting its stride. The company's been on a tear, pulling in RMB 10.084 billion during the first half of 2026—a remarkable 27.6% bump from last year. Not just content with the revenue surge, they also saw net profits jump 45.6%, making it pretty clear that they're not just playing...

Continue Reading

Top 5 Most Recently Viewed Articles

Market Insights: Global Central Banks and Currency Movements

Updated Category News Views 244

Global Market Overview and Central Bank Decisions Today's market outlook examines the actions of major global central banks and their potential effects on currencies and stocks. With a focus on current events, the central banks are in the spotlight. Bank of Japan's Decision The Bank of Japan has decided to maintain its current interest rates, which is in line with market...

Continue Reading
Texas Instruments Faces Stock Decline Post Q4 Earnings Report

Updated Category News Views 101

Texas Instruments Shares Decline After Q4 Earnings Announcement Texas Instruments Inc. (NASDAQ: TXN) announced its fourth-quarter earnings recently, leading to a noticeable dip in its stock price. Understanding the details of this financial report can provide insights for current and potential investors. Financial Performance in Q4 Texas Instruments recorded earnings...

Continue Reading
Unlocking America's Industrial Future: A New Hope Emerges

Updated Category News Views 190

A New Industrial Era on the Horizon Recent developments in U.S. manufacturing signal an exciting shift towards revitalizing American industry. Major players like Intel are investing in new semiconductor plants while Tesla increases its electric vehicle production domestically. Additionally, defense contractors are reshaping supply chains, igniting optimism for a 'Made in...

Continue Reading
DCI Advisors Limited Successfully Re-domiciles to Guernsey

Updated Category News Views 342

DCI Advisors Limited Announces Successful Re-domiciliation DCI Advisors Limited has recently made headlines with its significant decision to transition from its previous base in the British Virgin Islands to the scenic jurisdiction of Guernsey. This strategic move was underpinned by a successful shareholder vote during an Extraordinary General Meeting, affirming the...

Continue Reading
Y-mAbs Shares Q3 2024 Financial Outcomes and Strategic Moves

Updated Category News Views 75

Y-mAbs Reports Strong Q3 2024 Financials Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) recently announced its financial results for the third quarter of 2024, showcasing notable revenue achievements and strategic developments. The company reported total net product revenues of $18.5 million for the quarter, marking a significant step in its ongoing journey in the...

Continue Reading